Beware of Hypertension
November 12th, 2009 | 
Author: 
HYPERTENSION or high blood pressure is now a common disease in the society. Often sufferers do not realize it because this disease has no specific symptoms and suddenly have. In fact, if it is not handled properly, hypertension has a great risk making its sufferers to die from cardiovascular complications such as stroke, heart or kidney failure.
Higher rates of hypertension epidemiology in the world, has been pushed to do some research that aims to suppress the number of morbidity and mortality from this disease. This study was not only intended to control blood pressure, but also to protect vital organs from damage due to hypertension. Including a study result from ONTARGET (Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial).
This study do random clinical testing, double-blind which evaluates more than 25,260 patients that having high risk of cardiovascular disease. ONTARGET is not a hypertension study, because patients with blood pressure> 160/100 mm Hg is not included, but included patients with normal and controlled blood pressure.
The study that have been evaluated by Boehringer Ingelheim which conducted in nine Asian countries, China, Taiwan, Thailand, Singapore , Malaysia, Philippines, India, Japan and Korea in 2001, has reported its results on March 31, 2008. Proving that, if Telmisartan, is an antihypertensive drug classified in Modern Angiotensin II Receptor Blocker (ARB). Which can provide protection equal to ramipril, which is a golden standard of treatment of hypertension. And telmisartan can reduce the risk of death from cardiovascular disease.
Image: www.pdxgreens.org
Posted in